Nicolas Poirier
Director Ejecutivo en OSE IMMUNOTHERAPEUTICS .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Nicolas Poirier
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OSE IMMUNOTHERAPEUTICS | Director/Miembro de la Junta | 26/06/2019 | - |
Director Ejecutivo | 07/10/2022 | - | |
Director Técnico/Científico/I+D | 31/05/2016 | 07/10/2022 |
Historial de carrera de Nicolas Poirier
Antiguos cargos conocidos de Nicolas Poirier.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Corporate Officer/Principal | 01/01/2012 | - |
Formación de Nicolas Poirier.
University of Nantes | Graduate Degree |
Centre d'Etudes Supérieures de Techniques Industrielles | Undergraduate Degree |
Louis Pasteur University | Graduate Degree |
Estadísticas
Internacional
Francia | 6 |
Operativa
Graduate Degree | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OSE IMMUNOTHERAPEUTICS | Health Technology |
Empresas privadas | 1 |
---|---|
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |
- Bolsa de valores
- Insiders
- Nicolas Poirier
- Experiencia